Health News (Reuters)

Japan wins WTO dispute over Fukushima-related food

TOKYO/SEOUL (Reuters) - The World Trade Organization largely upheld a Japanese complaint against South Korean import bans and additional testing requirements imposed on Japanese seafood because of the 2011 Fukushima nuclear disaster.

Soccer is basically medicine, some researchers argue

(Reuters Health) - Compared to inactive people, recreational soccer players have lower cholesterol, blood pressure and resting heart rates as well as less fat mass, a research review suggests.

Blacks in U.S. lose quality of life due to fewer knee replacements

(Reuters Health) - Black people with knee osteoarthritis may have a worse quality of life than white patients in part because they’re less likely to be offered knee replacement surgery or to get the procedure when it’s recommended, a U.S. study suggests.

Sangamo in $3 billion gene-editing deal with Gilead

(Reuters) - U.S. drugmaker Gilead Sciences Inc will use Sangamo Therapeutics Inc's gene-editing technology to develop cancer treatments in a deal potentially worth about $3 billion to Sangamo, the companies said on Thursday.

Novo's pioneering diabetes pill impresses in first big study

COPENHAGEN/LONDON (Reuters) - The world's largest diabetes drugmaker, Novo Nordisk, on Thursday presented the first successful data from a large final-stage study of a pill it hopes will transform the diabetes market.

Study seeks to end antidepressant debate: the drugs do work

LONDON (Reuters) - A vast research study that sought to settle a long-standing debate about whether or not anti-depressant drugs really work has found they are indeed effective in relieving acute depression in adults.

Eating carbs not linked to risk for PMS

(Reuters Health) - The amount of foods containing sugars or other carbohydrates that a woman eats has nothing to do with the likelihood she will start experiencing premenstrual syndrome (PMS), researchers say.

Mesoblast stem cell therapy meets goal of pediatric Graft vs. Host study

(Reuters) - Nearly 70 percent of children with potentially fatal acute Graft Versus Host Disease responded to treatment with an experimental stem cell therapy from Mesoblast Ltd, meeting the primary goal of a late-stage U.S. trial, the Australian company announced on Wednesday.

U.S. health officials reverse stance on AstraZeneca's flu vaccine

(Reuters) - AstraZeneca Plc said on Wednesday an advisory committee of the U.S. Centers for Disease Control and Prevention recommended the use of its FluMist Quadrivalent vaccine in the upcoming flu season, reversing its earlier position.

Venezuelans report big weight losses in 2017 as hunger hits

CARACAS (Reuters) - Venezuelans reported losing on average 11 kilograms (24 lbs) in body weight last year and almost 90 percent now live in poverty, according to a new university study on the impact of a devastating economic crisis and food shortages.

Cigars and pipes tied to same risks as cigarettes

(Reuters Health) - Cigarettes are not the only type of tobacco products that can lead to premature death or fatalities from smoking-related cancers, a U.S. study confirms.

Pages